Scientists probe Kids' brain tumors for genetic clues and drug weaknesses
NCT ID NCT07417072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to better understand pediatric brain tumors by analyzing tumor and blood samples from 50 children aged 3-18. Researchers will use advanced genetic tests and create 3D tumor models in the lab to see how different chemotherapy drugs affect the cells. The goal is to uncover why some tumors resist treatment and to pave the way for more personalized therapies in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIGENETIC are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Meyer Children's Hospital IRCCS
RECRUITINGFlorence, Firenze, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads MRI scans to reveal hidden brain tumor types in children before surgery
- Can a 'Dojo' training boost Scientists' skills? new trial aims to find out
- Urine test could revolutionize thyroid cancer Follow-Up
- New MRI technique may grade Kids' brain tumors without a biopsy
- Scientists hunt for hidden causes of painful leg ulcers in sickle cell disease
- New registry to monitor radiation side effects in young cancer patients